{
    "clinical_study": {
        "@rank": "132954", 
        "arm_group": [
            {
                "arm_group_label": "intravenous", 
                "arm_group_type": "Experimental", 
                "description": "the total intravenous anesthesia group"
            }, 
            {
                "arm_group_label": "inhalation", 
                "arm_group_type": "Active Comparator", 
                "description": "the inhalation anesthesia group"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the effect of total intravenous anesthesia and\n      inhalation anesthesia on cancer cell cytotoxicity, micrometastasis and recurrence of tumor\n      in patients undergoing breast tumor resection. Using propofol-remifentanil in total\n      intravenous anesthesia group and sevoflurane -remifentanil in inhalation anesthesia group."
        }, 
        "brief_title": "Comparison of the Effect of Total Intravenous Anesthesia and Inhalation Anesthesia on Cancer Cell Cytotoxicity, Micrometastasis and Recurrence of Tumor in Patients Undergoing Breast Tumor Resection", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Breast Cancer", 
        "condition_browse": {
            "mesh_term": "Breast Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patient between 20 and 65 of age with ASA physical status \u2160-\u2162\n\n          -  breast cancer patients with no sign of local invasion (adjacent organs) and distant\n             metastasis revealed by imaging studies\n\n          -  surgery performed by the same surgical team\n\n        Exclusion Criteria:\n\n          -  ASA physical status \u2163\n\n          -  hepatic and renal impairment\n\n          -  diabetes or other endocrine disorders\n\n          -  body mass index > 35 kg/m2\n\n          -  immune disorders or immunosuppressive therapy\n\n          -  steroid treatment in the last 6 months\n\n          -  inflammation"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 12, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02089178", 
            "org_study_id": "4-2013-0937"
        }, 
        "intervention": [
            {
                "arm_group_label": "intravenous", 
                "description": "total intravenous anesthesia group: propofol-remifentanil", 
                "intervention_name": "intravenous anesthesia", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "inhalation", 
                "description": "inhalation anesthesia group: sevoflurane-remifentanil", 
                "intervention_name": "inhalation anesthesia", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "intravenous", 
                "intervention_name": "propofol-remifentanil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "inhalation", 
                "intervention_name": "sevoflurane-remifentanil", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Propofol", 
                "Sevoflurane", 
                "Remifentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor", 
        "lastchanged_date": "March 14, 2014", 
        "location": {
            "contact": {
                "email": "koobn@yuhs.ac", 
                "last_name": "Bon Nyeo Koo, MD", 
                "phone": "82-2-2228-2420"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "120-752"
                }, 
                "name": "Severance Hospital"
            }, 
            "investigator": {
                "last_name": "Bon Nyeo Koo, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "koobn@yuhs.ac", 
            "last_name": "Bon Nyeo Koo, MD", 
            "phone": "82-2-2228-2420"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "comparison of the effect of total intravenous anesthesia and inhalation anesthesia on cancer cell cytotoxicity", 
            "measure": "number of NK cell", 
            "safety_issue": "No", 
            "time_frame": "at 24 hour after surgery."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02089178"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Yonsei University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yonsei University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}